4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > 顶生系统/SARS-CoV-2(COVID-19)S蛋白RBD(N440K),His标签(MALS验证)/1mg/SRD
商品详细顶生系统/SARS-CoV-2(COVID-19)S蛋白RBD(N440K),His标签(MALS验证)/1mg/SRD
顶生系统/SARS-CoV-2(COVID-19)S蛋白RBD(N440K),His标签(MALS验证)/1mg/SRD
顶生系统/SARS-CoV-2(COVID-19)S蛋白RBD(N440K),His标签(MALS验证)/1mg/SRD
商品编号: SRD
品牌: ACROBiosystems
市场价: ¥52000.00
美元价: 26000.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Synonym
    Spike,S protein RBD,Spike glycoprotein Receptor-binding domain,S glycoprotein RBD,Spike protein RBD,COVID-19
  • Source
    SARS-CoV-2 S protein RBD (N440K), His Tag (SRD-C52H2) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession # QHD43416.1(N440K)).
    Predicted N-terminus: Arg 319
    Request for sequence
  • Molecular Characterization
    Online(Arg 319 - Lys 537) QHD43416.1 (N440K)

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 26.6 kDa. The protein migrates as 32-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
SARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. SRD-C52H2) SDS-PAGE gel

SARS-CoV-2 S protein RBD (N440K), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS
SARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. ) MALS images

The purity of SARS-CoV-2 S protein RBD (N440K), His Tag(Cat. No. SRD-C52H2) was more than 90% and the molecular weight of this protein is around 30-40 kDa verified by SEC-MALS.

Report
Bioactivity-ELISA
SARS-CoV-2 S protein RBD (N440K), His TagSARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. SRD-C52H2) ELISA bioactivity

Immobilized Human ACE2, Fc Tag (Cat. No. AC2-H5257) at 1 μg/mL (100 μL/well) can bind SARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. SRD-C52H2) with a linear range of 10-78 ng/mL (QC tested).

Protocol
SARS-CoV-2 S protein RBD (N440K), His TagSARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. SRD-C52H2) ELISA bioactivity

Immobilized Anti-SARS-CoV-2 RBD Neutralizing Antibody, Human IgG1 (Cat. No. SAD-S35) at 1 μg/mL (100 μL/well) can bind SARS-CoV-2 S protein RBD (N440K), His Tag (Cat. No. SRD-C52) with a linear range of 5-39 ng/mL (Routinely tested).

Protocol
  • Background
    It"s been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
  • References
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

品牌介绍
ACROBiosystems 是一个具有全球范围影响力的生物技术领导品牌,其运营包括了位于北美、 欧洲和亚洲的数家公司, 主要为生命科学研究、生物制药与疫病诊断等行业提供产品、技术服务和临床应用等解决方案,同时致力于在蛋白组学、药物发现和细胞治疗等领域推广面向工业化和临床转化的技术和产品。ACROBiosystems 的业务遍及全球50多个国家和地区,并通过在北美、亚洲、欧洲等世界范围的不同时区设立分支机构以服务于当地客户与经销商。